Prot #SGI-110-03: A Phase 2 Study of SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Subjects Who Failed Prior Treatment With Sorafenib

Project: Research project

Project Details

StatusFinished
Effective start/end date2/15/13 → 2/15/19

Funding

  • Astex Pharmaceuticals, Inc. (Prot #SGI-110-03)